Digostics Limited

Watch Video

Lab quality diabetes testing, at home.

About Us

Introduction

50% of adults living with diabetes remain undiagnosed.

Given the significant population health implications of missed or delayed detection, an immediate step-change is required in how we test for diabetes.

Digostics offers the world's first and only alternative to in-clinic oral glucose tolerance testing (OGTT) by enabling this crucial diabetes test to be performed at home.

Simplified testing. Increased patient throughput. Better outcomes.

Revolutionising Diabetes Testing

The OGTT remains the gold standard in diabetes testing. However, the test takes over two hours to perform. Furthermore, the complexity involved means it is only offered in clinics.

The inconvenience of clinic OGTT for patients and the provisioning challenges posed for healthcare professionals are significant reasons why total patient testing volumes consistently fall short of targets in standard of care.

It’s time for something different.

GTT@home is a revolutionary new OGTT home-testing service from Digostics comprised of a simple-to-use device that enables diabetes testing on a date and at a location of the patient's choosing.

Let's take the test to the patient.

Improving Access to OGTT

Everyone should have timely and convenient access to OGTT.

And yet, late or missed tests are common as in-clinic OGTT becomes increasingly difficult to schedule, deliver and attend.

GTT@home empowers healthcare providers to offer OGTT to those who need it, when they need it. And without concern as to how the associated test workload will be managed.

Similarly, patients get to test safely from home, with minimal disruption to daily routines and with the ability to have their results sent immediately to those responsible for their care.

A win-win for patients and healthcare professionals alike.

Greater testing capacity. Faster diagnoses.

GTT@home ensures more patients can be easily tested, on time.

It provides clinic-equivalent test performance. But significantly, without any of the staffing overheads, risks of sample degradation and laboratory delays that frequently impact clinic testing capacity.

By eliminating in-clinic tests, GTT@home enables more testing, faster results, and where warranted, an unparalleled opportunity for early clinical intervention.

About Digostics

Far too many people, in all geographies, are living with undiagnosed diabetes.

Digostics' mission is to enable healthcare providers to detect everyone with diabetes, and those at risk of developing diabetes, by eliminating the common barriers that inhibit testing and prevent the timely return of accurate diagnoses.

Digostics is proud to offer GTT@home - the most accessible and scalable way for clinical teams to realise their diabetes testing objectives.

Datasheet: Digostics Overview - Click to View

Datasheet: Introduction to GTT@home - Click to View

Datasheet: GTT@home for Diabetes in Pregnancy - Click to View

Evaluation Poster: GTT@home - An Alternative to In-Clinic Testing - Click to View